Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007201
Chunk: 108

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 108
---
 exercise, excluding for purposes of such determination Ordinary Shares issuable upon exercise
of such warrants which have not been exercised. The beneficial ownership limitation may be increased or decreased, provided that in no
event shall it exceed 9.99%, upon notice to us, provided that any increase in the beneficial ownership limitation shall not be effective
until 61 days following the receipt of such notice by us. The number of shares in the table below does not reflect this limitation. See
“Plan of Distribution.” The selling shareholders may sell all, some or none of their Ordinary Shares in this offering.
See “Plan of Distribution.”

| 70 |

| Name of Selling Shareholder                   |     | Number of Ordinary 
 Shares Owned Prior 
 to                 
 Offering **        |               |     | Maximum Number of  
 Ordinary Shares to 
 be Sold            
 Pursuant to this   
 Prospectus **      |             |     | Number of          
 Ordinary           
 Shares Owned After 
 Offering** (1)     |             |     | Percentage     
 of             
 Ordinary       
 Shares         
 Owned          
 after the      
 Offering (%)** 
 *              |     |
| Bigger Capital Fund, LP (2)                   |     |                    |   843,460,000 |     |                    | 425,520,000 |     |                    | 417,940,000 |     |                | 1.6 |
| Brio Capital Master Fund Ltd. (3)             |     |                    | 1,160,720,000 |     |                    | 851,060,000 |     |                    | 309,660,000 |     |                | 1.2 |
| Cavalry Fund I LP (4)                         |     |                    | 1,579,290,000 |     |                    | 851,060,000 |     |                    | 728,230,000 |     |                | 2.8 |
| District 2 Capital Fund LP (5)                |     |                    |   878,570,000 |     |                    | 425,520,000 |     |                    | 453,050,000 |     |                | 1.7 |
| Iroquois Capital Investment Group LLC (6)     |     |                    |   656,970,000 |     |                    | 553,180,000 |     |                    | 103,790,000 |     |                |   * |
| Iroquois Master Fund LP (7)